» Articles » PMID: 34634090

Common Communicable Diseases in the General Population in France During the COVID-19 Pandemic

Overview
Journal PLoS One
Date 2021 Oct 11
PMID 34634090
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In France, social distancing measures have been adopted to contain the spread of COVID-19, culminating in national Lockdowns. The use of hand washing, hydro-alcoholic rubs and mask-wearing also increased over time. As these measures are likely to impact the transmission of many communicable diseases, we studied the changes in common infectious diseases incidence in France during the first year of COVID-19 circulation. We examined the weekly incidence of acute gastroenteritis, chickenpox, acute respiratory infections and bronchiolitis reported in general practitioner networks since January 2016. We obtained search engine query volume for French terms related to these diseases and sales data for relevant drugs over the same period. A periodic regression model was fit to disease incidence, drug sales and search query volume before the COVID-19 period and extrapolated afterwards. We compared the expected values with observations made in 2020. During the first lockdown period, incidence dropped by 67% for gastroenteritis, by 79% for bronchiolitis, by 49% for acute respiratory infection and 90% for chickenpox compared to the past years. Reductions with respect to the expected incidence reflected the strength of implemented measures. Incidence in children was impacted the most. Reduction in primary care consultations dropped during a short period at the beginning of the first lockdown period but remained more than 95% of the expected value afterwards. In primary care, the large decrease in reported gastroenteritis, chickenpox or bronchiolitis observed during the period where many barrier measures were implemented imply that the circulation of common viruses was reduced and informs on the overall effect of these measures.

Citing Articles

The economic burden of varicella among children in France: a caregiver survey.

Samant S, Haas H, Santos J, Mink D, Pitman R, Petigara T Eur J Pediatr. 2024; 183(12):5233-5243.

PMID: 39367140 PMC: 11527928. DOI: 10.1007/s00431-024-05763-5.


Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.

Thongmee T, Chansaenroj J, Klinfueng S, Aeemjinda R, Wanlapakorn N, Poovorawan Y Hum Vaccin Immunother. 2024; 20(1):2367283.

PMID: 39051458 PMC: 11275523. DOI: 10.1080/21645515.2024.2367283.


Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.

Newson R, Divino V, Boye K, Chen J, DeKoven M, Vallarino C Diabetes Ther. 2024; 15(6):1435-1449.

PMID: 38683494 PMC: 11096291. DOI: 10.1007/s13300-024-01583-w.


Antibiotic Resistance of in Nasopharyngeal Carriage of Children with Acute Otitis Media and in Middle Ear Fluid from Otorrhea.

Assad Z, Cohen R, Varon E, Levy C, Bechet S, Corrard F Antibiotics (Basel). 2023; 12(11).

PMID: 37998807 PMC: 10668799. DOI: 10.3390/antibiotics12111605.


Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France.

De Thoisy A, Woudenberg T, Pelleau S, Donnadieu F, Garcia L, Pinaud L Open Forum Infect Dis. 2023; 10(7):ofad340.

PMID: 37496603 PMC: 10368309. DOI: 10.1093/ofid/ofad340.


References
1.
Costagliola D, Flahault A, Galinec D, Garnerin P, Menares J, Valleron A . A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health. 1991; 81(1):97-9. PMC: 1404927. DOI: 10.2105/ajph.81.1.97. View

2.
Pullano G, Valdano E, Scarpa N, Rubrichi S, Colizza V . Evaluating the effect of demographic factors, socioeconomic factors, and risk aversion on mobility during the COVID-19 epidemic in France under lockdown: a population-based study. Lancet Digit Health. 2020; 2(12):e638-e649. PMC: 7598368. DOI: 10.1016/S2589-7500(20)30243-0. View

3.
Cowling B, Ali S, Ng T, Tsang T, Li J, Fong M . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5(5):e279-e288. PMC: 7164922. DOI: 10.1016/S2468-2667(20)30090-6. View

4.
Sullivan S, Carlson S, Cheng A, Chilver M, Dwyer D, Irwin M . Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020; 25(47). PMC: 7693168. DOI: 10.2807/1560-7917.ES.2020.25.47.2001847. View

5.
Pelat C, Turbelin C, Bar-Hen A, Flahault A, Valleron A . More diseases tracked by using Google Trends. Emerg Infect Dis. 2009; 15(8):1327-8. PMC: 2815981. DOI: 10.3201/eid1508.090299. View